Related Experiment Video

Updated: Nov 19, 2025

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

59.4K

Patents Related to Pathogenic Human Coronaviruses

Michelli Dos Santos1, André V F Ferreira1, Jonatas O da Silva1

  • 1Laboratório de Biotecnologia de Microrganismos, Universidade Federal de São João Del-Rei, Sebastião Gonçalves Coelho, 400, 355901-296, Divinópolis, MG, Brazil.

Recent Patents on Biotechnology
|January 28, 2021
PubMed
Abstract

Insights

Intellectual property databases reveal numerous patents for coronaviruses like SARS-CoV, MERS-CoV, and SARS-CoV-2. These patents highlight promising strategies for diagnosis, treatment, and prevention of these public health threats.

Area of Science:

  • Virology
  • Public Health
  • Intellectual Property

Background:

  • Coronaviruses, including SARS-CoV, MERS-CoV, and SARS-CoV-2, pose significant global health risks.
  • Past and recent outbreaks underscore the urgent need for research into diagnosis, treatment, and prevention.

Purpose of the Study:

  • To analyze patent data related to pathogenic coronaviruses.
  • Focus on patents filed between 2019 and 2020 within Google Patents.

Main Methods:

  • Keyword-based search in Google Patents (April 2020).
  • Keywords included "SARS", "SARS-CoV", "MERS", "MERS-CoV", "SARS-CoV-2", and "COVID-19".
  • Analysis of 191 patents, with 25 selected for detailed description.

Main Results:

  • 191 patents were analyzed, with the majority (149) related to SARS-CoV.
  • 29 patents focused on MERS-CoV and 12 on SARS-CoV-2.
  • Patents covered diverse areas: diagnosis, therapeutics, prevention, and control.

Conclusions:

  • Intellectual property databases contain promising strategies for combating coronaviruses.
  • Further research is needed to understand pathogenesis and optimize diagnostic and therapeutic approaches.
  • Patent analysis provides insights into innovation trends for emerging infectious diseases.
Keywords:
COVID-19CoronavirusesHCoVsMERSSARSpandemicpatents

More Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-208:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.1K
Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions09:02

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions

Published on: September 22, 2023

1.8K

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.4K
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.4K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
37.5K
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
307